Table 2—

Standardized regression coefficients of total breaks with metabolic risk variables

Metabolic risk variableβ (95% CI)PAdjusted R2
Waist circumference (cm) −0.16 (−0.31 to −0.02) 0.027 0.26 
BMI (kg/m2−0.19 (−0.35 to −0.02) 0.026 0.05 
Triglycerides (log) (mmol/l)* −0.18 (−0.34 to −0.02) 0.029 0.13 
HDL cholesterol (mmol/l)* 0.03 (−0.12 to 0.18) 0.685 0.25 
Systolic blood pressure (mmHg) −0.03 (−0.18 to 0.12) 0.697 0.21 
Diastolic blood pressure (mmHg) 0.03 (−0.12 to 0.19) 0.670 0.19 
Fasting plasma glucose (mmol/l) −0.09 (−0.25 to 0.07) 0.287 0.09 
2-h plasma glucose (mmol/l) −0.18 (−0.34 to −0.02) 0.025 0.14 
Metabolic risk variableβ (95% CI)PAdjusted R2
Waist circumference (cm) −0.16 (−0.31 to −0.02) 0.027 0.26 
BMI (kg/m2−0.19 (−0.35 to −0.02) 0.026 0.05 
Triglycerides (log) (mmol/l)* −0.18 (−0.34 to −0.02) 0.029 0.13 
HDL cholesterol (mmol/l)* 0.03 (−0.12 to 0.18) 0.685 0.25 
Systolic blood pressure (mmHg) −0.03 (−0.18 to 0.12) 0.697 0.21 
Diastolic blood pressure (mmHg) 0.03 (−0.12 to 0.19) 0.670 0.19 
Fasting plasma glucose (mmol/l) −0.09 (−0.25 to 0.07) 0.287 0.09 
2-h plasma glucose (mmol/l) −0.18 (−0.34 to −0.02) 0.025 0.14 

Adjusted for age, sex, employment, alcohol intake, income, education, smoking, family history of diabetes, diet quality, moderate- to vigorous-intensity time, mean intensity of breaks, and total sedentary time.

*

Additional adjustment for lipid-lowering medication;

additional adjustment for hypertensive medication. Adjusted R2 gives an estimate of explained variance, taking into account the sample size.

Close Modal

or Create an Account

Close Modal
Close Modal